Xentuzumab
Xentuzumab (BI836845) is a recombinant monoclonal antibody to humanised IGF ligand that inhibits IGF1 and IGF2 growth-promoting signalling and inhibits AKT activation for the study of solid tumours.
Product Specifications
CAS Number
1417158-65-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Akt | IGF-1R
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
